Rankings
▼
Calendar
PEN Q4 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena
PEN
Penumbra, Inc.
$13B
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$316M
+10.8% YoY
Gross Profit
$211M
66.8% margin
Operating Income
$43M
13.6% margin
Net Income
$34M
10.7% margin
EPS (Diluted)
$0.86
QoQ Revenue Growth
+4.8%
Cash Flow
Operating Cash Flow
$51M
Free Cash Flow
$46M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$382M
Stockholders' Equity
$1.2B
Cash & Equivalents
$324M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$316M
$285M
+10.8%
Gross Profit
$211M
$187M
+12.7%
Operating Income
$43M
$35M
+22.1%
Net Income
$34M
$54M
-37.9%
Geographic Segments
UNITED STATES
$248M
79%
Other Non-US
$68M
21%
← FY 2024
All Quarters
Q1 2025 →